View drug registration information details.
Items | Registration information |
ID | 1717 |
No | 1717 |
Brand Name | LUCIELACE |
Ingredients | ELACESTRANT 86 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 30'S/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | TREATMENT OF POSTMENOPAUSAL WOMEN OR ADULT MEN, WITH ER POSITIVE, HER2 NEGATIVE, ESR1 MUTATED ADVANCED OR METASTATIC BREAT CANCER WITH DISEASE PROGRESSION FOLLOWING AT LEAST ONE LINE OF ENDOCRINE THERAPY |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | BLUE, ROUND TABLET, WITH LETTER LUS ON ONE SIDE AND PLAIN ON THE OTHER SIDE |
Note | |
License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 09 L 1197/24 |
FDD Registration Date | 24-SEP-2024 |
Expiry Date | 23-SEP-2029 |
Back to drug list
|